UCL Discovery Stage
UCL home » Library Services » Electronic resources » UCL Discovery Stage

Plasminogen activator inhibitor-1 and tissue plasminogen activator and incident AF: Data from the PREVEND study

Mulder, BA; Geelhoed, B; van der Harst, P; Spronk, HM; Van Gelder, IC; Asselbergs, FW; Rienstra, M; (2018) Plasminogen activator inhibitor-1 and tissue plasminogen activator and incident AF: Data from the PREVEND study. International Journal of Cardiology , 272 pp. 208-210. 10.1016/j.ijcard.2018.08.029. Green open access

[thumbnail of 1-s2.0-S0167527318344073-main.pdf]
Preview
Text
1-s2.0-S0167527318344073-main.pdf - Published Version

Download (235kB) | Preview

Abstract

BACKGROUND: Tissue-type plasminogen activator (TPA) and plasminogen activator inhibitor-1 (PAI-1) have been shown to be associated with increased risk for stroke, however, the association with incident atrial fibrillation (AF) is unknown. METHODS: We examined 8265 individuals included in the PREVEND study. In all subjects, PAI-1 and TPA plasma/serum levels were measured using an ELISA kit. By means of univariate and multivariate analyses the association with incident AF was assessed. RESULTS: Mean age was age 49 ± 13 years, and 50% were women. Of the 8265 patients free of AF at baseline, 267 (3.2%) patients developed incident AF during a mean follow-up of 9.7 ± 2.4 years. Baseline median levels of PAI-1 and TPA were 72.4 ng/ml and 3.1 ng/ml, respectively. In univariate analyses PAI-1 (Hazard ratio [HR] 1.10 95% Confidence interval [CI] 1.04–1.16, p < 0.001) and TPA (HR 1.05, 95% CI 1.01–1.08, p = 0.014) were associated with incident AF. However, after multivariate adjustment for age, sex, antihypertensive drugs, stroke, heart failure, myocardial infarction, diabetes mellitus, peripheral arterial disease, smoking, NT-proBNP, alcohol consumption, body mass index no significant association was found. CONCLUSION: In this community-based cohort, PAI-1 and TPA levels were not associated with incident AF.

Type: Article
Title: Plasminogen activator inhibitor-1 and tissue plasminogen activator and incident AF: Data from the PREVEND study
Open access status: An open access version is available from UCL Discovery
DOI: 10.1016/j.ijcard.2018.08.029
Publisher version: https://doi.org/10.1016/j.ijcard.2018.08.029
Language: English
Additional information: © 2018 The Authors. Published by Elsevier B.V. This is an open access article under the CC BY-NC-ND license (http:// creativecommons.org/licenses/by-nc-nd/4.0/).
Keywords: PAI-1, TPA, Atrial fibrillation
UCL classification: UCL
UCL > Provost and Vice Provost Offices > School of Life and Medical Sciences
UCL > Provost and Vice Provost Offices > School of Life and Medical Sciences > Faculty of Population Health Sciences > Institute of Health Informatics
URI: https://discovery-pp.ucl.ac.uk/id/eprint/10055001
Downloads since deposit
5,852Downloads
Download activity - last month
Download activity - last 12 months
Downloads by country - last 12 months

Archive Staff Only

View Item View Item